Overview
ADULT syndrome (Acro-Dermato-Ungual-Lacrimal-Tooth syndrome) is a rare ectodermal dysplasia caused by mutations in the TP63 gene located on chromosome 3q27. This condition affects multiple body systems derived from the ectoderm, including the skin, nails, lacrimal (tear) ducts, teeth, and limbs. ADULT syndrome shares clinical features with other TP63-related disorders such as EEC syndrome (Ectrodactyly-Ectodermal dysplasia-Clefting syndrome) and Limb-Mammary syndrome, but is distinguished by its specific combination of features and typically the absence of orofacial clefting. Key clinical features include ectrodactyly (split hand/foot malformation) or other limb anomalies, excessive freckling or other skin changes, nail dysplasia (abnormal or underdeveloped nails), lacrimal duct obstruction leading to chronic tearing and recurrent eye infections, and dental anomalies such as early loss of permanent teeth, hypodontia (missing teeth), or small teeth. Patients may also have thin or sparse hair, dry skin, and mammary gland or nipple hypoplasia. The severity and combination of features can vary considerably even within the same family. There is currently no cure for ADULT syndrome. Treatment is symptomatic and supportive, tailored to the individual's specific manifestations. This may include surgical correction of limb malformations, dental prosthetics or implants for tooth abnormalities, probing or surgical repair of blocked lacrimal ducts, dermatologic care for skin findings, and regular monitoring by a multidisciplinary team including geneticists, dermatologists, ophthalmologists, dentists, and orthopedic specialists. Genetic counseling is recommended for affected individuals and their families.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Neonatal
Begins at or shortly after birth (first 4 weeks)
FDA & Trial Timeline
10 eventsPetrovsky National Research Centre of Surgery — NA
Varol TUNALI — NA
Vor Biopharma — PHASE3
Nest Genomics — NA
Yale University — NA
Fundacion Miguel Servet — NA
Wesper Inc — NA
Riphah International University — NA
University of Calgary — PHASE1
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for ADULT syndrome.
1 clinical trialare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to ADULT syndrome.
Community
No community posts yet. Be the first to share your experience with ADULT syndrome.
Start the conversation →Latest news about ADULT syndrome
Disease timeline:
New recruiting trial: Antiviral Clinical Trial for Long Covid-19
A new clinical trial is recruiting patients for ADULT syndrome
New recruiting trial: Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
A new clinical trial is recruiting patients for ADULT syndrome
New recruiting trial: DEnosumab for the Treatment of FIbrous Dysplasia/McCune-Albright Syndrome in Adults (DeFiD)
A new clinical trial is recruiting patients for ADULT syndrome
New recruiting trial: Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
A new clinical trial is recruiting patients for ADULT syndrome
New recruiting trial: A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis
A new clinical trial is recruiting patients for ADULT syndrome
New recruiting trial: A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome
A new clinical trial is recruiting patients for ADULT syndrome
New recruiting trial: Melatonin's Effect on Nighttime Blood Pressure and Sleep in OSA Patients (MEBP-OSA)
A new clinical trial is recruiting patients for ADULT syndrome
New recruiting trial: Prescription of Step Counts for Targeted Changes in Body Composition and Cardiometabolic Risk in Overweight/Obese Adults
A new clinical trial is recruiting patients for ADULT syndrome
New recruiting trial: A Phase 1b Study to Investigate Safety and Tolerability of ARGX-119 in Adult Participants With DOK7-Congenital Myasthenic Syndromes (CMS)
A new clinical trial is recruiting patients for ADULT syndrome
New recruiting trial: Sleep Apnea in Elderly
A new clinical trial is recruiting patients for ADULT syndrome
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about ADULT syndrome
What is ADULT syndrome?
ADULT syndrome (Acro-Dermato-Ungual-Lacrimal-Tooth syndrome) is a rare ectodermal dysplasia caused by mutations in the TP63 gene located on chromosome 3q27. This condition affects multiple body systems derived from the ectoderm, including the skin, nails, lacrimal (tear) ducts, teeth, and limbs. ADULT syndrome shares clinical features with other TP63-related disorders such as EEC syndrome (Ectrodactyly-Ectodermal dysplasia-Clefting syndrome) and Limb-Mammary syndrome, but is distinguished by its specific combination of features and typically the absence of orofacial clefting. Key clinical fea
How is ADULT syndrome inherited?
ADULT syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does ADULT syndrome typically begin?
Typical onset of ADULT syndrome is neonatal. Age of onset can vary across affected individuals.
Are there clinical trials for ADULT syndrome?
Yes — 1 recruiting clinical trial is currently listed for ADULT syndrome on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat ADULT syndrome?
25 specialists and care centers treating ADULT syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.